Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

490
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
490
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

119
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
119
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bi-level Multi-criteria Optimization for Risk-informed Radiotherapy.

Physics in medicine and biology·2026
Same author

Response to: "Smarter dose, or simply more dose? clarifying the clinical signal in ERI-guided Bayesian rectal radiotherapy".

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Corrigendum to "Clinical target volumes for glioma - Automated delineation to improve neuroanatomic consistency" [Phys. Imaging Radiat. Oncol. 36 (2025) 100865].

Physics and imaging in radiation oncology·2026
Same author

Improving the composition of donor milk using machine learning and optimisation techniques.

PloS one·2026
Same author

Integrating biomarker-derived individual treatment response assessment into Bayesian trial design for personalized cancer treatment.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Probabilistic clinical target definition with nearest neighbor correlation.

Physics in medicine and biology·2025
Same journal

Deep learning-based dose prediction to enhance planning efficiency in cervical brachytherapy with hybrid applicators.

Physics in medicine and biology·2026
Same journal

Corrigendum: Referenceless MR thermometry-a comparison of five methods (2017<i>Phys. Med. Biol</i>.<b>62</b>1-16).

Physics in medicine and biology·2026
Same journal

Corrigendum: Measured and Monte Carlo simulated electron backscatter to the monitor chamber for the varian TrueBeam linac (2016<i>Phys. Med. Biol</i>.<b>61</b>8779).

Physics in medicine and biology·2026
Same journal

Corrigendum: 3D range-modulator for scanned particle therapy: development, Monte Carlo simulations and experimental evaluation (2017<i>Phys. Med. Biol</i>.<b>62</b>7075).

Physics in medicine and biology·2026
Same journal

Recent progress in applications of computing to radiotherapy (ICCR 2016).

Physics in medicine and biology·2026
Same journal

Novel TMS coils designed using an inverse boundary element method.

Physics in medicine and biology·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Embedding machine learning based toxicity models within radiotherapy treatment plan optimization.

Donato Maragno1, Gregory Buti2, Ş İlker Birbil1

  • 1Amsterdam Business School, University of Amsterdam, Amsterdam, The Netherlands.

Physics in Medicine and Biology
|February 27, 2024
PubMed
Summary
This summary is machine-generated.

This study developed a personalized radiotherapy framework using optimization with constraint learning to reduce radiation-induced toxicity. The approach significantly lowered the risk of radiation pneumonitis in lung cancer patients without compromising tumor coverage.

Keywords:
NSCLCconstraint learningmachine learningoptimizationpersonalized treatment planningradiation pneumonitisradiation-induced toxicity

More Related Videos

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K

Related Experiment Videos

Last Updated: May 1, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

2.8K
Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.3K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Computational Biology

Background:

  • Radiotherapy (RT) poses challenges due to radiation-induced toxicity (RIT).
  • Personalized treatment planning is crucial for minimizing adverse side effects.
  • Existing methods often lack integration between toxicity prediction and treatment optimization.

Purpose of the Study:

  • To develop and evaluate a personalized radiotherapy treatment planning framework using optimization with constraint learning (OCL).
  • To leverage patient-specific data and machine learning to predict and mitigate radiation pneumonitis (RP2+) in non-small cell lung cancer (NSCLC) patients.
  • To reduce RIT while maintaining target coverage in RT.

Main Methods:

  • Implemented a three-step OCL framework: baseline plan optimization, ML-based RIT prediction, and patient-specific constraint adaptation.
  • Utilized classification trees, ensemble methods, and neural networks to predict RP2+ probability.
  • Assessed the methodology on four high-risk NSCLC patients, comparing OCL-enhanced plans with conventional plans.

Main Results:

  • The OCL framework successfully integrated predictive models into RT planning.
  • Mean lung dose and V20 were reduced, leading to an average RP2+ risk reduction from 95% to 42%.
  • Tumor coverage was maintained, with minor increases in spinal cord max-dose in some cases.

Conclusions:

  • The OCL framework effectively reduces radiation pneumonitis risk in NSCLC patients.
  • Integrating patient-specific data into learned constraints enhances personalized RT decision-making.
  • This approach bridges the gap between toxicity prediction and treatment optimization for improved patient outcomes.